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Ischemia-reperfusion injury (IRI) of the lung is one ofthe common pathophysiological phenomena, en-countered in clinical cases of trauma, shock, car- diopulmonary bypass, lung transplant, bronchial sleeveresection, etc. Ischemic postconditioning (IPO) is theprocess whereby the blood flow to an ischemic part is
resumed by immediate single or multiple brief
reperfusion/re-occlusion cycles, thus making that or-
gan more resistant to the previous long standing
ischemia.1 Heme oxygenase (HO) is a rate-limiting
enzyme in the degradation of heme and under condi-
tion of stress. HO especially HO-1 has a protective effect,
which limits ischemia-reperfusion injury to organs.2 Our
earlier study has already confirmed the protective effect
of HO-1 protein against endotoxin-induced acute lung
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Objective:    To investigate the effect of ischemic
postconditioning (IPO) on acute lung ischemia-reperfusion
(I/R) injury and the protein expression of haeme oxygenase-1
(HO-1), a cytoprotective defense against oxidative injury.
Methods:    After being anesthetized with chloralhy-
drate, forty-eight healthy SD rats were randomly divided
into 6 groups (8 in each): sham operation group (S group); I/R
group: left lung hilum was clamped for 40 minutes followed
by 105 minutes of reperfusion; IPO group: left lung hilum
was clamped for 40 minutes and postconditioned by  3 cycles
of 30 seconds of reperfusion and 30 seconds of reocclusion;
Hemin (HM)+ I/R group: hemin, an inducer of HO-1 was
injected intraperitoneally at 40 µmol·kg-1 ·day-1 for two con-
secutive days prior to 40 minutes clamping of left lung hilum;
ZnPPIX+IPO group: zinc protoporphyrin IX,  an inhibitor of
HO-1 was injected intraperitoneally at 20 mg·kg-1  24 hours
prior to  40 minutes clamping of left lung hilum;  and HM+S
group: HM was administered as in the HM+I/R group without
inducing lung I/R. Arterial partial pressure of oxygen (PaO2)
and malondialdehyde (MDA) content in serum were assessed.
The left lung was removed for determination of wet/dry lung
weight ratio and expression of HO-1 protein by immuno-his-
tochemical technique and for light microscopic examination.
Results:   The PaO2 was significantly lower in all the
experimental groups compared with sham group (90 mm Hg
±11 mm Hg). However, the values of PaO2 in  IPO (81 mm Hg
±7 mm Hg) and HM+I/R (80 mm Hg±9 mm Hg) were higher
than that in  I/R (63 mm Hg±9 mm Hg) and ZnPPIX+IPO (65
mm Hg±8 mm Hg) groups (P<0.01). The protein expression
of HO-1 in lung tissue was significantly increased in I/R
group compared with S group (P<0.01). While the HO-1
protein expression was higher in IPO and HM+I/R groups
as compared with I/R group (P<0.05, P<0.01). The lung wet/
dry (W/D) weight ratio and MDA content in serum were
significantly increased in I/R group as compared with  S or
HM+S groups (P<0.01), accompanied by severe lung tissue
histological damage, which was attenuated either by IPO or
by HM pretreatment (P<0.01, IPO or HM+I/R vs. I/R). The
protective effect of IPO was abolished by ZnPPIX.
Conclusion:    Ischemic postconditioning can attenuate
the lung ischemia-reperfusion injury through upregulating
the protein expression of HO-1 that leads to reduced post-
ischemic oxidative damage.
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injury; Lung; Heme oxygenase-1; Malondialdehyde
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injury.3 Other experiments have shown that IPO can
decrease reperfusion injury to heart muscle, liver4 and
kidney5.But the literature about the protective effect of
IPO against lung IRI is still scarce. The participation of
HO-1 in the protective mechanism of IPO is still
unknown. This research is mainly concerned about the
expression of HO-1 protein, the effect and mechanism
of IPO during ischemia-reperfusion injury of the lung.
METHODS
Reagents and instruments
Hemin and zinc protoporphyrin IX were purchased
from Sigma Company (USA), and HO-1 polyclonal an-
tibody was from Boster Biological Technology Ltd
(Wuhan,China), MDA detection kit from Nanjing
Jiancheng Shengwu Company Limited (Nanjing, China),
DW-2000 animal mechanical ventilator from Shanghai
Jiapeng Technical Company (Shanghai, China), I-STAT
handheld blood gas analyzer from Hong Kong Lixin Yiqi
Company Limited (Hong Kong, China), Olympus BX50
microphotographic system and HPIAS-2000 model im-
age analysis software from Wuhan Qianli Technical Im-
aging Company Limited (Wuhan, China).
Animal grouping and model preparation
Sprague-Dawley (SD) rats were provided by Wuhan
University Medical College Animal Lab Centre. Forty-
eight specific-pathogen-free (SPF) rats, of either sex
with body weight of 210 g±20 g, were randomly as-
signed to 6 groups (8 in each): sham operation group
(S group), ischemia/reperfusion group (I/R group), is-
chemic postconditioning group (IPO group), hemin+
ischemia/reperfusion group (HM+I/R group), zinc pro-
toporphyrin IX+ischemic postconditioning group
(ZnPPIX+IPO group) and hemin + sham operation group
(HM+S group). Before the experiment, the rats were
abstained from food for 12 hours but free to drink water
at any time. Anesthesia was given by injection of 7%
chloral hydrate 5 ml/kg intraperitoneally. Tracheotomy
and intubation were performed, and the animals were
ventilated with room air via the ventilator. The left femo-
ral vein was catheterized and 3:1 crystalloid to colloi-
dal fluid mixture was infused intravenously. The right
femoral artery was catheterized and connected to a
monitoring unit to continuously monitor mean arterial pres-
sure (MAP) and collect blood samples. Thoracotomy
was performed at the level of the 5th intercostal space,
exposing the hilum of the left lung. A dose of 500 U/kg
of heparin was given intravenously for anticoagulation.
After 5 minutes, at the end of inspiratory phase, the
hilum of the left lung was clamped using a non-trau-
matic clamp (without collapsing the lobes).
Rats in S group were allowed to a continuous perfu-
sion for 150 minutes. I/R group rats were kept ischemic
for 40 minutes by clamping the left hilum and reperfused
for 105 minutes. IPO group rats were maintained is-
chemia for 40 minutes, then postconditioning was per-
formed by three cycles of 30-second reperfusion and
30-second ischemia, and finally reperfused for 102
minutes. HM+I/R group rats was intraperitoneally in-
jected with hemin at a rate of 40 µmol·kg-1·day-1 for 2
consecutive days prior to the experiment and then the
same procedure was performed as group I/R. ZnPPIX
group+IPO group rats were intraperitoneally injected with
zinc protoporphyrin IX (20 mg·kg-1·day-1) 24 hours prior
to the experiment and the rest of the procedures were
the same as IPO group. HM+S group rats were handled
preoperatively as HM+I/R group and intraoperatively as
S group. The rats that did not have any preoperative
intraperitoneal injection with ZnPPIX or HM, were in-
jected with an identical dose of normal saline.
Measurement
Blood samples were drawn from the femoral artery
to determine PaO2 level at 20 minutes (T1) after me-
chanical ventilation and at the end of the experiment
(T2). Immediately after the experiment, 2 ml of blood
was collected and centrifuged for 10 minutes at a tem-
perature of 4°C and rotational speed of 4000 r/min. Then
the serum was extracted and stored at -70°C. Accord-
ing to the instruction of the MDA kit, thiobarbituric acid
method was used to determine the concentration of
malondialdehyde (MDA) level. Part of the left lung was
dissected and dried at a constant temperature of 80°C
for 24 hours to obtain a dehydrated consistency. The
ratio of wet weight to dry weight (W/D) was calculated.
A section of 0.5 cm×0.5 cm in size was dissected from
the left lung and  fixed in 10% formalin for 24 hours. It
was dehydrated in gradient alcohol and then in xylene.
The sample was embedded in paraffin and then slices
of 4 µm thick were made on slides. The slices were
stained by SABC method. For the determination of HO-1,
at a magnification of 400×, the buffy granules were set
as a positive unit product of HO-1 protein. Eight visual
fields (not overlapping with each other) were randomly
selected from each slide. A semiquantitative analysis
Chinese Journal of Traumatology 2009; 12(3):162-166. 164 .
of expression of HO-1 was performed by measuring the
positive granule average optical density value (OD value),
using HPIAS-2000 high resolution color picture analy-
sis system. The HE stained lung tissue slides were
viewed under the light microscope to observe the patho-
logical changes.
Statistical method
Measured data are expressed as mean ± standard
deviation. Intergroup comparison analysis was done
using a single factor variance and intragroup by
Student’s t test. All calculations were done using SPSS
14.0 statistics software. Variance for P<0.05 was set
to have statistical significance.
RESULTS
Within each group, the body weight, gender and
baseline of MAP did not have any statistical signifi-
cance (P>0.05).
Effect of ischemic postconditioning on arterial PaO2
level
 The baseline of PaO2 between each group did not
have statistical difference (P>0.05), but there was a
considerable decrease in the values of PaO2 of all the
groups (P<0.01) except HM+S group. When compared
with S group, there were significantly decreased values
of postoperative PaO2 level in I/R, IPO, HM+I/R and
ZnPPIX+IPO groups. I/R group had lower PaO2 value
than IPO, HM+I/R, HM+S groups (P<0.05 or 0.01, Table 1).
Effect on lung tissue W/D, serum MDA level and
expression of HO-1 protein
I/R, IPO, HM+I/R and ZnppIX+IPO groups showed
elevated values of lung tissue W/D when compared with
S group (P<0.05 or 0.01); as for  HM+S group, the
differences of this parameter did not have any statisti-
cal significance (P>0.05). The lower values of lung tis-
sue W/D ratio and MDA level were observed in I/R, IPO,
HM+I/R and HM+S groups in comparison with I/R group
(P<0.01). An obviously higher lung tissue expression
of HO-1 protein was seen in I/R, IPO, HM+I/R, and
HM+S groups than that in S group (P<0.01). As com-
pared with I/R group, there was a stronger expression
of HO-1 protein in IPO and  HM+I/R groups and a
weaker expression in HM+S group (P<0.05 or 0.01).
(Table 2 and Fig. 1)
Table 1.  Changes in arterial partial pressure of oxygen
in different groups (n=8, mean±SD, mmHg)
 Groups              Basic values (T1)        Postoperative values (T2)
S
I/R
IPO
HM+I/R
ZnPPIX+IPO
HM+S
92 ± 10
91 ± 10
92 ± 13
91 ± 9
89 ± 12
89 ± 12
90 ± 11
63 ± 9 *＃＃
81 ± 7 *＃☆
79 ± 10 *＃ ☆
65 ± 8 *＃＃
89 ± 10☆
*P<0.01 compared with the basic value within groups; ＃ P<0.05,
＃＃ P<0.01 compared with S group; ☆ P<0.01 compared with I/R group.
Effect of ischemic postconditioning on the lung tis-
sue morphology (Fig. 2)
S group: The structure of the alveoli was clear and
alveolar wall was thin and intact. There was no hemor-
rhage or edema.
I/R group: Destruction of the alveolar structure was
noted and partial alveolar compensating emphysema
was seen. In the alveolar space there was exudate,
thickening of the alveolar septum and massive inflam-
matory cell infiltration with hemorrhage.
IPO and HM+I/R groups: The extent of pathological
injury in these two groups was milder than that in I/R
group with a narrowing alveolar septum and mild in-
flammatory cell infiltration and hemorrhage.
ZnPPIX+IPO group: The pathological injury degree
was similar to Group I/R.
HM+S group: The alveolar structure was normal.
Table 2. Serum MDA, lung tissue W/D and expression of
HO-1 protein in different groups (n=8, χ ± s)
 Groups    MDA (nmol/ml)         W/D                   HO-1
S
I/R
IPO
HM+I/R
ZnPPIX+IPO
HM+S
3.77 ± 0.57
6.46 ± 0.73 **
4.62 ± 0.39 ** ##
4.46 ± 0.42 * ##
6.70 ± 0.46 **
3.58 ± 0.50 # #
3.97 ± 0.43
5.97 ± 0.69 **
4.66 ± 0.37 **#
4.71 ± 0.45 **#
5.69 ± 0.52 **
4.05 ± 0.50 ##
0.111 ± 0.016
0.177 ± 0.015 *
0.194 ± 0.017 **#
0.209 ± 0.013 **##
0.114 ± 0.018 #
0.117 ± 0.019 #
*P<0.05,  **P<0.01 compared with S group;  #P<0.05, ##P<0.01
compared with I/R group.
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DISCUSSION
A lung IRI model was established in rats by clamp-
ing and releasing the hilum of the left lung through a
thoracotomy incision. In light of past studies 6 and many
preliminary experiments, ischemic postconditioning was
implemented by 3 cycles of 30-second reperfusion/30-
second re-occlusion by unclamping and clamping the
hilum of the left lung. The dosage and administration
method of HM and ZnPPIX were derived from prelimi-
nary experiments and the literatre.7,8 The results show
that the lung with ischemia followed by an uninterrupted
reperfusion, has an increase in lung tissue W/D and
serum MDA level, and a decrease in arterial PaO2
(P<0.01), thereby indicating that lung tissue ischemia/
reperfusion wil l cause pulmonary edema, lipid
peroxidation injury and a decrease in lung oxygenation
capacity. Hence, the preparation of IRI model is
successful.
Compared with I/R group, there is a net ameliora-
tion in lung tissue W/D, arterial PaO2 and serum MDA
levels (P<0.01) in IPO group, indicating that IPO has a
certain protective effect against reperfusion injury in lung
tissue. It is believed that lung IRI is an injury factor and
a pathophysiological process, dynamically developed
by the protective mechanism of the organism. And HO-1
acts as a type of stress protein that participates in the
injury/anti-injury pathophysiological mechanism of the
body and this issue is presently gaining a general in-
terest among scholars. In some recent researches, it
has been found that HO-1 has an important effect on
lung IRI and most probably it participates in stress coun-
teracting reaction in cells.9 Under the condition of I/R of
the lung, superoxide anions, hydrogen peroxide, hy-
droxyl radicals, free hemoglobin and heme will induce
oxidative stress injury and HO-1/CO pathway activa-
tion in the lung. HO-1 catalyses the products of
biliverdin, ferrous ions and CO through diverse regula-
tory effects and complex signal transduction pathways,
10 thus maintain a stable lung homeostasis and reduce
tissue injury. There are more and more evidences that
CO and bilirubin have a protective role in lung injury and
transplantation. From our results, the expression of HO-1
is enhanced in I/R group, suggesting that I/R can in-
duce lung injury and at the same time it triggers the
protective mechanism  involving HO-1.10
Moreover, the results suggest that the administra-
tion of a specific HO-1 inducer, hemin, for 2 consecu-
tive days prior to IRI will lead to an increase of lung
tissue HO-1 protein expression, and a decrease of W/
D and serum MDA. PaO2  is close to the normal level.
Thus it is evident that the induced expression of HO-1
protein may decrease oxygen radical assault to lung
parenchyma. Pretreatment by an HO-1 inhibitor, ZnPPIX
did not show significant difference between ZnPPIX+IPO
group and I/R group (P>0.05) in spite of using IPO be-
fore reperfusion. Therefore, IPO fails to show protective
effect when HO-1 protein expression is suppressed. In
the lung, the protective effect of IPO against IRI prob-
ably involves the induction of high expression of HO-1
protein. Some researches have confirmed that the acti-
vation of HO-1 limits the production of NO and the syn-
thesis of peroxynitrite in the process of ischemia. High
expression of HO-1 provides protective effect against
ischemia/reperfusion injury.11 Stimuli triggering HO-1
gene activation has a common feature, e.g. to initiate
Fig. 1. Lung tissue expression of HO-1 protein in different groups (SABC, 400×).
            S group                          I/R group                         IPO group               HM+I/R group             ZnPPIX+IPO group              HM+S group
Fig. 2. Histopathology of lung tissue in different groups (HE, 200×).
            S group                          I/R group                         IPO group               HM+I/R group             ZnPPIX+IPO group              HM+S group
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oxidative stress (which destroys cellular redox
equilibrium). In other words, the expression of HO-1
protein will not be elevated if there is no oxidative stress
injury. Hemin does not have effect on the organism at
normal condition even if hemin is administered as a
premedication, which explains why HM+S group has a
weaker expression of HO-1 than I/R group (P<0.05).
Based on past and present researches, we can
assume that the protective effect of IPO against IRI of
the lung is probably related to the following factors:(1)
brief repetitive intermittent reperfusion and re-occlusion
limits regional blood flow, decreases the production of
oxygen radical in the reperfused area and stimulates
the release of intracellular antioxidase and free radical
scavengers, thus attenuates the injury due to lipid
peroxidation;(2) IPO is given as a slow and dose-gradu-
ally increased way, which may decrease vascular dis-
tention and exosmosis due to the sudden increase in
reperfusion pressure, thereby reduce lung tissue injury
and edema;(3) IPO, by inducing HO-1, indirectly at-
tenuates  lung tissue injury, but the mechanism is to
be clarified.
In summary, early transient ischemic postconditioning
can attenuate IRI of the lung and this process involves
the expression of HO-1 protein and inhibition of lipid
peroxidation.
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